The next-generation KRAS G12C inhibitor MK-1084 showed promising efficacy and safety as a single agent and in combinations ...

Immutep’s efti with radiotherapy and pembrolizumab meets primary endpoint in phase II trials for soft tissue sarcoma ...

Paweł’s decision reflects a growing challenge in Poland’s labour market. An ageing population and historically low ...

Novel combination with efti has met the trial's primary endpoint of tumour hyalinization/fibrosis in the neoadjuvant setting for patients with resectable soft tissue sarcomaDetailed results are planne ...

CEO Marc Voigt delivers an update on the company’s recent clinical milestones, highlighting significant progress across multiple cancer indications. The focus of the presentation is the company’s ...

Efti combination demonstrates significant tumor response in sarcoma trial, exceeding expectations without chemotherapy.

In his 2024 book, Fear/Less: Why Your Lifelong Fears Are Probably Groundless, Professor Wojciech Janicki, who's based at the University of Maria Curie-Sklodowska in Poland, recounted some of the ...

I am therefore satisfied with these announcements," said Maria Leptin ... she wants to "strengthen" the highly appreciated Marie Sklodowska-Curie fellowships, which support young researchers.

was named in honour of the Polish Nobel Prize winner Maria Sklodowska-Curie. Its construction began in June 1970, and it was launched in December 1974. It is a water and beryllium moderated high flux ...

In 2021,we established the “Marie Sklodowska Curie Award”, together with the Embassy of the ... be offered an opportunity to visit research institutions in Poland, where Maria was born and raised, by ...

Wojciech Jurczak, MD, PhD, head of the department of oncology at Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Poland, discusses the future of B-cell lymphoma therapy, with ...

Wojciech Jurczak, MD, PhD, head of the department of oncology at Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Poland, discusses advancements in B-cell lymphoma therapy, ...